DrugsControl Media Services

News Detail

US FDA recommends steps to improve diversity in clinical trials (27-06-2024)

Maryland, 27 June 2024: The US Food and Drug Administration (FDA) published a much-anticipated draft guidance that recommends more diverse patient cohorts in clinical trials and is meant to improve the data the agency receives in support of premarket applications. It broadly desc......
View Details

Source : Regulatory Affairs Professionals Society
US Food and Drug Administration (FDA) draft guidance clinical trials Diversity Action Plans

Related News